RLMD insider transaction filings
RELMADA THERAPEUTICS, INC. — 47 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-11. Screen RLMD transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 2 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 2 filings by 2 insiders — 400,000 shares, $1,671,990 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 120,200 shares @ $4.20 ($504,840) by Shenouda Maged, filed 2026-09-11.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Shenouda Maged — Chief Financial Officer | 1 | 2 legs · 200,000 sh · $843,990 | — | — |
| TRAVERSA SERGIO — Chief Executive Officer, Director | 1 | 2 legs · 200,000 sh · $828,000 | — | — |
Recent Form 4 filings — RELMADA THERAPEUTICS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Purchase (P): 100,000 @ $4.18 · Purchase (P): 100,000 @ $4.10 | EDGAR |
| 2026-09-11 | 4 | Shenouda Maged — Chief Financial Officer | Purchase (P): 120,200 @ $4.20 · Purchase (P): 79,800 @ $4.25 | EDGAR |
| 2025-12-16 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Purchase (P): 27,500 @ $4.12 · Grant/award (A): 1,198,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Shenouda Maged — Chief Financial Officer | Purchase (P): 11,665 @ $4.12 · Grant/award (A): 828,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Ence Chuck — CA and CO | Grant/award (A): 828,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Fedeli Fabiana — Director | Grant/award (A): 164,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | GLASSPOOL JOHN — Director | Grant/award (A): 164,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Kelly Paul Edward — COO, Director | Grant/award (A): 828,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | CASAMENTO CHARLES J — Director | Grant/award (A): 164,000 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | Ence Chuck — CAO and COO | Purchase (P): 136,000 @ $2.20 | EDGAR |
| 2025-11-06 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Purchase (P): 272,500 @ $2.20 | EDGAR |
| 2025-11-06 | 4 | Shenouda Maged — Chief Financial Officer | Purchase (P): 500,000 @ $2.20 | EDGAR |
| 2025-11-06 | 4 | Kelly Paul Edward — Chief Operating Officer, Director | Purchase (P): 90,000 @ $2.20 | EDGAR |
| 2025-08-28 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Purchase (P): 80,545 @ $0.62 · Purchase (P): 129,455 @ $0.67 · Purchase (P): 55,976 @ $0.74 | EDGAR |
| 2025-06-30 | 4 | Ence Chuck — CA and CO | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Shenouda Maged — Chief Financial Officer | Grant/award (A): 600,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | GLASSPOOL JOHN — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Fedeli Fabiana — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Kelly Paul Edward — Chief Operating Officer, Director | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | CASAMENTO CHARLES J — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Kelly Paul Edward — Chief Operating Officer, Director | Purchase (P): 200,000 @ $0.43 | EDGAR |
| 2025-05-20 | 4 | Shenouda Maged — Chief Financial Officer | Purchase (P): 50,000 @ $0.44 · Purchase (P): 90,000 @ $0.49 · Purchase (P): 60,000 @ $0.52 | EDGAR |
| 2025-05-20 | 4 | Ence Chuck — CA and CO | Purchase (P): 228,961 @ $0.45 | EDGAR |
| 2025-05-20 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Purchase (P): 172,314 @ $0.45 · Purchase (P): 30,000 @ $0.50 · Purchase (P): 147,686 @ $0.56 | EDGAR |
| 2024-10-23 | 4 | CASAMENTO CHARLES J — Director | Gift (G): 13,000 @ $0 | EDGAR |
| 2024-09-11 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Purchase (P): 55,579 @ $2.71 · Purchase (P): 33,014 @ $2.75 · Purchase (P): 51,407 @ $2.99 | EDGAR |
| 2024-09-11 | 4 | Shenouda Maged — Chief Financial Officer | Purchase (P): 8,194 @ $2.55 · Purchase (P): 21,118 @ $2.73 · Purchase (P): 24,120 @ $2.95 | EDGAR |
| 2024-09-11 | 4 | Kelly Paul Edward — Director | Purchase (P): 25,000 @ $2.59 | EDGAR |
| 2024-09-11 | 4 | CASAMENTO CHARLES J — Director | Purchase (P): 13,000 @ $2.56 | EDGAR |
| 2024-05-29 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Grant/award (A): 122,358 (derivative) @ $0 · Other (J): 122,358 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | Shenouda Maged — Chief Financial Officer | Grant/award (A): 54,624 (derivative) @ $0 · Other (J): 54,624 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | Kelly Paul Edward — Director | Grant/award (A): 43,700 (derivative) @ $0 · Other (J): 43,700 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | GLASSPOOL JOHN — Director | Grant/award (A): 20,976 (derivative) @ $0 · Other (J): 20,976 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | Fedeli Fabiana — Director | Grant/award (A): 20,976 (derivative) @ $0 · Other (J): 20,976 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | Ence Chuck — CA and CO | Grant/award (A): 54,624 (derivative) @ $0 · Other (J): 54,624 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | CASAMENTO CHARLES J — Director | Grant/award (A): 20,976 (derivative) @ $0 · Other (J): 20,976 (derivative) @ $0 | EDGAR |
| 2024-01-31 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Purchase (P): 31,541 @ $3.71 · Purchase (P): 40,999 @ $3.90 · Purchase (P): 27,460 @ $4.00 | EDGAR |
| 2024-01-31 | 4 | Shenouda Maged — Chief Financial Officer | Purchase (P): 10,800 @ $3.65 · Purchase (P): 15,000 @ $3.89 · Purchase (P): 6,875 @ $4.06 | EDGAR |
| 2024-01-31 | 4 | Ence Chuck — CA and CO | Purchase (P): 10,800 @ $3.65 · Purchase (P): 14,500 @ $3.87 · Purchase (P): 13,670 @ $4.05 | EDGAR |
| 2023-12-19 | 4 | TRAVERSA SERGIO — Chief Executive Officer, Director | Grant/award (A): 183,881 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4 | Shenouda Maged — Chief Financial Officer | Grant/award (A): 82,090 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4 | Kelly Paul Edward — Director | Grant/award (A): 65,672 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4 | GLASSPOOL JOHN — Director | Grant/award (A): 31,522 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4 | Fedeli Fabiana — Director | Grant/award (A): 31,522 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4 | Ence Chuck — Chief Accounting and CO | Grant/award (A): 82,090 (derivative) @ $0 | EDGAR |
| 2023-12-19 | 4 | CASAMENTO CHARLES J — Director | Grant/award (A): 31,522 (derivative) @ $0 | EDGAR |
Recent 8-K events — RELMADA THERAPEUTICS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-08 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-28 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-28 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-20 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RLMD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →